Navigation Links
NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
Date:3/26/2008

rmulation product candidate, NGX-1998, in the first half of 2008."

Regulatory and Commercialization Plans for NGX-4010

NeurogesX submitted an MAA for NGX-4010, which was accepted by the EMEA under the centralized filing procedure in September 2007. The Company's MAA seeks approval in the European Union for a broad indication of peripheral neuropathic pain, which includes PHN, HIV-DSP and PDN, among others. The submission was based upon existing clinical trial data, which as of the date of the filing included the Company's first two successful Phase 3 studies, one each in PHN and HIV-DSP. NeurogesX is evaluating strategies regarding its MAA that may include adding to the dossier the Company's second successful Phase 3 study in PHN (C117) and its second Phase 3 study in HIV-DSP (C119), in which the primary endpoint was not met, to potentially support broad label approval, or approval of a subset of indications in neuropathic pain.

NeurogesX expects to submit an NDA for NGX-4010 with the FDA in the second half of 2008 for PHN. The Company is currently evaluating its clinical and regulatory strategies with regard to the HIV-DSP indication, including the potential for conducting additional studies to support an approval in this indication.

NeurogesX retains exclusive worldwide commercialization rights for NGX- 4010 and intends to establish a focused specialty sales force in the United States to address its target market of pain centers and physicians. NeurogesX intends to enter into commercial partnerships for marketing and distribution outside the United States.

Fourth Quarter and Year-End 2007 Financial Results

For the three months ended December 31, 2007, total operating expenses were approximately $8.1 million, including $0.3 million of non-cash stock- based compensation expense, compared to total operating expenses of approximately $9.3 million, including $2.0 million of non-cash stock-based compensation expense, for the sam
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007
2. NeurogesX to Present at RBC Capital Markets 2007 Healthcare Conference
3. NeurogesX to Present at Susquehanna Financial Groups 2nd Annual SIGnificant Options in Healthcare Conference
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... As part of a company-wide ... in San Diego and surrounding areas, Golden ... care team with ongoing online training courses. , ... provided by Caregiverlist®. Caregiverlist® is “the premiere ... most reliable eldercare options, highest quality ratings and ...
(Date:12/22/2014)... December 22, 2014 Fad diets ... The reason why most fad diets have hung around ... problem with fad diets is that, as the body becomes ... dieter uncertain of how to reset the metabolism to return ... Diet Doc developed their all-inclusive diet plans that ...
(Date:12/22/2014)... LENEXA, Kan. (PRWEB) December 22, 2014 ... it will add a subscription option to their ad ... for report writing services. Customers can sign up for ... report writing hours each month at a deeply discounted ... pricing tiers, and each has a progressively discounted rate. ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 On December ... joined by Pastor Gordon Cashwell for an episode to ... asks Gordon, “Why is it so important to you ... Jesus?” Cashwell replies, “We all should respect who Jesus ... was founded on Christian beliefs. That means that on ...
(Date:12/22/2014)... Harrisburg, NC (PRWEB) December 22, 2014 ... contain the current Ebola virus epidemic are ... by U.S. government agencies, nongovernmental organizations (NGOs) ... solutions remains ongoing, healthcare workers, emergency responders, ... advanced technologies such as the CmTP ...
Breaking Medicine News(10 mins):Health News:Golden Care Partners with Nationally Recognized Caregiver Training Service 2Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 2Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 3Health News:Diet Doc Announces the Difference Between Fad Diets and Real Weight Loss Programs to Help Dieters Make the Best Choice 4Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:My Positive Perspective Celebrates Christmas With an Event to Celebrate the Birthday of Jesus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5
... Expands Coty-DKMS: Linked Against Leukemia PartnershipWARSAW, Poland, Feb. 25 ... industry and the world,s largest fragrance company, and DKMS, ... pleased to announce the opening of DKMS Polska, the ... global initiative. DKMS was inspired by Coty to open ...
... Feb. 25 In a unified effort to ... in Michigan, MidMichigan Health will go trans fat ... fats will be eliminated from patient meals, cafeteria ... shelves at MidMichigan Medical Centers in Alma, Clare, ...
... Mark Leventhal, Esq., the Founder and President of Leventhal ... executive weight loss consulting service for attorneys by an ... Association at 11:45 am today at Hellriegel,s Inn, 1840 ... a one-on-one personalized approach, and works with clients over ...
... Healthtech Institute, has announced the release of IND Submissions: A Primer, ... IND and applicable IND amendments. IND Submissions: A Primer is the ... ... Needham, MA (PRWEB) February 25, 2009 -- IND Submissions: A Primer ...
... physical activity and encourages healthy lifestylesWESTMINSTER, Colo., Feb. ... Westminster, CO, can now earn an extra $500 ... new health and wellness program, Virgin HealthMiles. Offered ... incentivizes and rewards healthy goals such as exercising, ...
... L.U.V. (Loyal, United, Vocal) Program encourages parents across the country ... Week February 22-28 "I found a note ... home from school. It said, ,I know you have ... TEEN ON-LINE CHAT FORUM)PHILADELPHIA, Feb. 25 Finding the right ...
Cached Medicine News:Health News:Coty Inc. and DKMS Announce the Opening of DKMS Polska 2Health News:Coty Inc. and DKMS Announce the Opening of DKMS Polska 3Health News:MidMichigan Health Cuts Out Trans Fats Beginning March 1 2Health News:Mark Leventhal to Address the Lake County (OH) Bar Association 2Health News:Barnett Releases IND Submissions: A Primer 2Health News:Barnett Releases IND Submissions: A Primer 3Health News:Barnett Releases IND Submissions: A Primer 4Health News:Dalbey Education Launches Health and Wellness Program 2Health News:The Renfrew Center Foundation Partners with 2008 Miss America Kirsten Haglund and Her Mom, Iora Haglund, to Empower Parents to Fight Eating Disorders 2Health News:The Renfrew Center Foundation Partners with 2008 Miss America Kirsten Haglund and Her Mom, Iora Haglund, to Empower Parents to Fight Eating Disorders 3
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 Swedish ... Inc. today announced that the Committee for Medicinal Products ... (EMA) has adopted a positive opinion for the use ... adult men with Peyronie,s disease with a palpable plaque ... the start of therapy. The use of ...
(Date:12/22/2014)... 22, 2014  Eiger BioPharmaceuticals Incorporated announced the ... lonafarnib in patients with chronic hepatitis delta virus ... National Institutes of Health (NIH) Clinical Center in ... randomized, placebo-controlled, dose ascending study evaluated two doses ... mg twice daily for 28 days.  "This proof-of-concept ...
(Date:12/22/2014)... , Dec. 22, 2014 TWi Biotechnology, ... of Allowance for AC-201, TWi Biotechnology,s lead drug ... China for patent application ... pharmaceutically acceptable salts, active metabolite for treatment of ... methods of treatment using AC-201 for type II ...
Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 2TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in China 3
... a large body for increased stability ... centimeters center-to-center) to resist the wear ... indicators are molded into the body. ... bar electrode styles. Shielded bar electrodes ...
... Cadwell's custom bars have a ... solid, machined contacts (spaced 3 centimeters ... tear of repeated cleaning. Polarity indicators ... convenient, snap-on handle fits our bar ...
The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
... Evolutionary refractive lens technology for ... safety and efficacy, demonstrates quality of ... contact lens correction. The lens is ... and is now available for the ...
Medicine Products: